ABSTRACT
The efficacy of sulphadoxine for the treatment of human malaria was first reported in 1964 (1). Soon thereafter it was found that potentiation took place when sulphadoxine was combined with pyrimethamine for treatment of malaria and monotherapy was abandoned.
